It is proposed that resistance to TGF-β-induced growth inhibition originates from downstream of TβR-induced phosphorylation, since the initial steps in the TGF-β signaling pathway, from receptor expression down to TβR-I phosphorylation, remain intact in primary ovarian cancer cells (19). The gene discussed is TGFB1; the disease is ovarian cancer.